Seroprevalence of rubella antibodies in the State of São Paulo, Brazil, 8 years after the introduction of vaccine

Vaccine

Volumn 21, Issue 25-26, 2003, Pages 3795-3800

  Zanetta, Dirce M T ^a   Cabrera, Eliana M S ^a   Azevedo, Raymundo S ^b   Burattini, Marcelo N ^b   Massad, Eduardo ^b  

^a Medicine School of São José Do Rio Preto FAMERP São José Do Rio Preto   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Rubella; Seroepidemiology; Vaccination

Indexed keywords

ANTIVIRUS AGENT; IMMUNOGLOBULIN G ANTIBODY; RUBELLA ANTIBODY; RUBELLA VACCINE;

ACTIVE IMMUNIZATION; ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; BRAZIL; CHILD; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGICAL DATA; FOLLOW UP; GROUPS BY AGE; HUMAN; HUMAN EXPERIMENT; INFANT; INFECTION PREVENTION; NORMAL HUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; RUBELLA; SEROPREVALENCE;

EID: 0242380644     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00315-3     Document Type: Article

References (14)

1. Knox E.G. Strategy for rubella vaccination. Int. J. Epidemiol. 9:1980;13-23.
2. Anderson R.M., May R.M. Vaccination against rubella and measles: quantitative investigations of different policies. J. Hyg. Camb. 90:1983;259-325.
3. Hethcote H.W. Measles and rubella in the United States. Am. J. Epidemiol. 117:1983;2-13.
4. van Druten J.A.M., de Boo Th., Plantinga A.D. Measles, mumps and rubella: control by vaccination. Dev. Biol. Stand. 65:1986;53-63.
5. Massad E., Burattini M.N., Azevedo Neto R.S., Yang H.M., Coutinho F.A.B., Zanetta D.M.T. A model-based design of a vaccination strategy against rubella in a non-immunized community of São Paulo State, Brazil. Epidemiol. Infect. 112:1994;579-594.
6. Robertson S.E., Cutts F.T., Samuel R., Diaz-Ortega J.L. Control of rubella and congenital rubella syndrome (CRS) in developing countries. Part 2. Vaccination against rubella. Bull. WHO. 75:1997;69-80.
7. Azevedo Neto R.S., Silveira A.S.B., Nokes D.J.et al. Rubella seroepidemiology in a non-immunized population of São Paulo State, Brazil. Epidemiol. Infect. 113:1994;161-173.
8. Massad E., Azevedo Neto R.S., Burattini M.N.et al. Assessing the efficacy of a mixed vaccination strategy against rubella in São Paulo, Brazil. Int. J. Epidemiol. 24:1995;842-850.
9. Coutinho F.A.B., Massad E., Burattini M.N., Yang H.M., Azevedo Neto R.S. Effects of vaccination programmes on transmission rates of infections and related threshold conditions for control. IMA J. Math. Appl. Med. Biol. 10:1993;187-206.
10. CVE, Center for Epidemiologic Surveillance. 2001. http://www.cve.sp.gov. br/htm/inf_tec_rub.htm.
11. CVE, Center for Epidemiologic Surveillance. 2002. http://www.cve.sp.gov. br/htm/rub_ob.htm.
12. Davidkin I., Peltola H., Leinikki P., Valle M. Duration of rubella immunity induced by two-dose measles. Vaccine. 18:2000;3106-3112.
13. Peltola H., Davidkin I., Paunio M., Valle M., Leinikki P., Heinonen O.P. Mumps and rubella eliminated from Finland. J. Am. Med. Assoc. 284:2000;2643-2647.
14. Johnson C.E., Kumar M.L., Whitwell J.K. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years. Pediatr. Infect. Dis. 15:1996;687-692.